ADVERTISEMENT
ADVERTISEMENT

Fate of science "hero" uncertain

Senator Arlen Specter, long-time champion of biomedical research, is facing tough reelection battle

kerry grens
Kerry Grens

Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at...

View full profile.


Learn about our editorial policies.

It isn't often that citizens from a single state in the union can dramatically shift the fate of research support in the United States, but Pennsylvania voters may have the chance on Tuesday (May 18). They head to the polls in a primary election that will determine whether democratic linkurl:Senator Arlen Specter;http://specter.senate.gov/public/ -- arguably the most celebrated champion of biomedical research in Congress -- will remain in his seat next year.
Arlen Specter
Image: Steve Dietz/Sharp Image
Specter, a decades-long incumbent, is challenged by a comparatively green Congressman, linkurl:Joe Sestak,;http://sestak.house.gov/ currently representing the state in the House of Representatives. Fueled by volleys of television advertising, which highlights Specter's recent switch from the Republican party (which Sestak's camp dubs "opportunistic"), Sestak has made a steady climb in the polls and has become a formidable opponent."We are following this [election] with great interest," said linkurl:Ellen Sigal,;http://www.focr.org/ellen-v-sigal-phd.html the chair of Friends of Cancer...
The ScientistThe Scientist



Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
ADVERTISEMENT